Expertise in
12
conditions

Klaus Mohnike

Leipziger Str. 44, 
Magdeburg, ST, DE 
Expertise in
12
conditions
Leipziger Str. 44, 
Magdeburg, ST, DE 
OverviewLocationsClinical Research

Overview

Klaus Mohnike practices in Magdeburg, Germany. Mr. Mohnike is highly rated in 12 conditions, according to our data. His top areas of expertise are Achondroplasia, Congenital Hyperinsulinism, Low Blood Sugar, Hormone Replacement Therapy (HRT), and Pancreatectomy.

His clinical research consists of co-authoring 94 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Leipziger Str. 44, Magdeburg, ST 39120, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: MOD-4023, Somatropin
Study Phase: Phase 3
An Open-Label Multiple-Dose Study of RZ358 in Patients With Congenital Hyperinsulinism
An Open-Label Multiple-Dose Study of RZ358 in Patients With Congenital Hyperinsulinism
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drug: RZ358
Study Phase: Phase 2
A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Drug, Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

92 Total Publications

EndoCompass project: research roadmap for diabetes, obesity, and metabolism.
EndoCompass project: research roadmap for diabetes, obesity, and metabolism.
Journal: European journal of endocrinology
Published: February 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mohnike's expertise for a condition
ConditionClose
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile